Skip to content
Health Horizon

Health Horizon

Healthy Body Your Time in Health

Primary Menu Health Horizon

Health Horizon

  • Health Horizon
  • Health Technology Innovation
  • Global Health and the Health Crisis
  • Mental Health and Emotional Wellbeing
  • Genetics and Gene Therapy Research
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • drug

drug

Supreme Court won’t stop Moncton mothers’ class-action suit over labour-inducing drug
  • Health Horizon

Supreme Court won’t stop Moncton mothers’ class-action suit over labour-inducing drug

admin July 25, 2025 0

Canada's top court will not review a New Brunswick court's decision allowing a class-action lawsuit by mothers who allege a Moncton Hospital...

Read MoreRead more about Supreme Court won’t stop Moncton mothers’ class-action suit over labour-inducing drug
Scientists overcome major challenge in gene therapy and drug delivery
  • Genetics and Gene Therapy Research

Scientists overcome major challenge in gene therapy and drug delivery

admin November 9, 2024 0

Imagine trying to poke a hole in the yolk of a raw egg without breaking the egg white. It sounds...

Read MoreRead more about Scientists overcome major challenge in gene therapy and drug delivery
Horizon Health, nurse deny wrongdoing in alleged misuse of labour-inducing drug
  • Health Horizon

Horizon Health, nurse deny wrongdoing in alleged misuse of labour-inducing drug

admin April 6, 2024 0

The nurse named in a proposed class-action lawsuit on behalf of women who were allegedly "inappropriately" given a labour-inducing drug...

Read MoreRead more about Horizon Health, nurse deny wrongdoing in alleged misuse of labour-inducing drug
Why drug resistance is becoming one of our biggest global health security blind-spots
  • Global Health and the Health Crisis

Why drug resistance is becoming one of our biggest global health security blind-spots

admin January 31, 2024 0

  A recent wave of increased hospitalizations for respiratory infections in Northern China is the result of Mycoplasma pneumoniae, a bacterial infection...

Read MoreRead more about Why drug resistance is becoming one of our biggest global health security blind-spots

Recent Posts

  • CDC in Nigeria | Global Health
  • Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Global Health Updates: US & WHO News
  • Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Archives

  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023

Categories

  • Genetics and Gene Therapy Research
  • Global Health and the Health Crisis
  • Health Horizon
  • Health Technology Innovation
  • Mental Health and Emotional Wellbeing
  • News

Visit Us

Quantum Quest for Quality

You may have missed

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0
Copyright © All rights reserved. | CoverNews by AF themes.